NDC11 67877025930
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 67877-0259-30 | 67877-0259 |
| 67877-259-30 | 67877-259 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rasagiline | RASAGILINE | Ascend Laboratories, LLC | 5dfeec8f-f4f3-4e06-915e-3244467516a6 | 2026-08-11 | Warnings, Adverse reactions | 67877-259-30 67877-259 67877025930 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.